The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients

Eur Respir J. 2019 May 18;53(5):1900055. doi: 10.1183/13993003.00055-2019. Print 2019 May.

Authors

Jana Kleinerova¹, Patricia Ging², Colin Rutherford², Iain Lawrie², Sara Winward², Donna Eaton², Karen C Redmond², Jim J Egan²

Affiliations

¹ National Heart and Lung Transplant Centre, Mater Misericordiae University Hospital, Dublin, Ireland janakleinerova@hotmail.com.
² National Heart and Lung Transplant Centre, Mater Misericordiae University Hospital, Dublin, Ireland.

PMID: 30819816
DOI: 10.1183/13993003.00055-2019

No abstract available

Publication types

Letter

MeSH terms

Aged
Female
Humans
Ireland / epidemiology
Lung Transplantation / mortality*
Male
Middle Aged
Postoperative Complications / epidemiology*
Pulmonary Disease, Chronic Obstructive / mortality
Pulmonary Disease, Chronic Obstructive / surgery*
Retrospective Studies
alpha 1-Antitrypsin Deficiency / mortality
alpha 1-Antitrypsin Deficiency / surgery*